Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 11
142
Views
0
CrossRef citations to date
0
Altmetric
Molecular Toxicology

Identification of gene expression markers and development of evaluation method using cell-based and RT-PCR-based assay for skin sensitising potential of chemicals

, , &
Pages 1359-1369 | Received 05 May 2020, Accepted 06 May 2020, Published online: 21 May 2020

References

  • Ade N, Leon F, Pallardy M, et al. (2009). HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol Sci 107:451–60.
  • Aiba S, Terunuma A, Manome H, Tagami H. (1997). Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 27:3031–8.
  • Adler S, Basketter D, Creton S, et al. (2011). Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol 85:367–485.
  • Arkusz J, Stępnik M, Sobala W, Dastych J. (2010). Prediction of the contact sensitizing potential of chemicals using analysis of gene expression changes in human THP-1 monocytes. Toxicol Lett 199:51–9.
  • Ashikaga T, Hoya M, Itagaki H, et al. (2002). Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicol In Vitro 16:711–6.
  • Ashikaga T, Sakaguchi H, Sono S, et al. (2010). A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern Lab Anim 38:275–84.
  • Ashikaga T, Yoshida Y, Hirota M, et al. (2006). Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol In Vitro 20:767–73.
  • Bocchietto E, Paolucci C, Breda D, et al. (2007). Human monocytoid THP-1 cell line versus monocyte-derived human immature dendritic cells as in vitro models for predicting the sensitising potential of chemicals. Int J Immunopathol Pharmacol 20:259–65.
  • Bouchon A, Dietrich J, Colonna M. (2000). Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164:4991–5.
  • Bouchon A, Facchetti F, Weigand MA, Colonna M. (2001). TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410:1103–7.
  • Chicheportiche Y, Bourdon PR, Xu HD, et al. (1997). TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272:32401–10.
  • Dennis G, Sherman BT, Hosack DA, et al. (2003). DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.
  • Directive 2003/15/EC. (2003). Directive 2003/15/EC of the European parliament and of the council of 27 February 2003 amending council directive 76/768/EEC on the approximation of the laws of the member states relating to cosmetic products. Official Journal of the European Union, L66, 26–35.
  • Dos Santos GG, Reinders J, Ouwehand K, et al. (2009). Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. Toxicol Appl Pharmacol 236:372–82.
  • Feng SLY, Guo Y, Factor VM, et al. (2000). The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol 156:1253–61.
  • Gerberick F, Aleksic M, Basketter D, et al. (2008). Chemical reactivity measurement and the predicitve identification of skin sensitisers. The report and recommendations of ECVAM Workshop 64. Altern Lab Anim 36:215–42.
  • Gerberick GF, Ryan CA, Kern PS, et al. (2005). Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 16:157–202.
  • Gibot S, Le Renard PE, Bollaert PE, et al. (2005). Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intens Care Med 31:594–7.
  • Goebel C, Aeby P, Ade N, et al. (2012). Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation. Regul Toxicol Pharmacol, 63:40–52.
  • Harada N, Nakayama M, Nakano H, et al. (2002). Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun 299:488–93.
  • Hirota M, Moro O. (2006). MIP-1beta, a novel biomarker for in vitro sensitization test using human monocytic cell line. Toxicol In Vitro 20:736–42.
  • Hooyberghs J, Schoeters E, Lambrechts N, et al. (2008). A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol Appl Pharmacol 231:103–11.
  • Huang DW, Sherman BT, Tan Q, et al. (2007). DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 35:W169–75.
  • Jin L, Nakao A, Nakayama M, et al. (2004). Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes. J Invest Dermatol 122:1175–9.
  • Karlberg AT, Bergstrom MA, Borje A, et al. (2008). Allergic contact dermatitis-formation, structural requirements, and reactivity of skin sensitizers. Chem Res Toxicol 21:53–69.
  • Kern PS, Gerberick GF, Ryan CA, et al. (2010). Local lymph node data for the evaluation of skin sensitization alternatives: a second compilation. Dermatitis 21:8–32.
  • Kimber I, Basketter DA, Gerberick GF, et al. (2011). Chemical allergy: translating biology into hazard characterization. Toxicol Sci 120:S238–S268.
  • Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–8.
  • Martinon F, Mayor A, Tschopp J. (2009). The inflammasomes: guardians of the body. Ann Rev Immunol 27:229–65.
  • Meighan-Mantha RL, Hsu DKW, Guo Y, et al. (1999). The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 274:33166–76.
  • Miyazawa M, Ito Y, Yoshida Y, et al. (2007). Phenotypic alterations and cytokine production in THP-1 cells in response to allergens. Toxicol In Vitro 21:428–37.
  • Nukada Y, Ashikaga T, Miyazawa M, et al. (2012). Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency. Toxicol in Vitro 26:1150–60.
  • OECD. (1992). Test No. 406: skin sensitisation. OECD guidelines for the testing of chemicals, section 4: health effects. Paris, France: OECD Publishing.
  • OECD. (2002). Test no. 429: skin sensitisation: the local lymph node assay, OECD guidelines for testing of chemicals, section 4: health effects. Paris, France: OECD Publishing.
  • OECD. (2010a). Test no. 429: skin sensitisation: the local lymph node assay, OECD guidelines for testing of chemicals, section 4: health effects. Paris, France: OECD Publishing.
  • OECD. (2010b). Test no. 442A: skin sensitization: the local lymph node assay: DA, OECD guidelines for the testing of chemicals, section 4: health effects. Paris, France: OECD Publishing.
  • OECD. (2014). The adverse outcome pathway for skin sensitisation initiated by covalent binding to proteins. OECD series on testing and assessment, No. 168. Paris, France: OECD Publishing.
  • OECD. (2018). Test no. 442E: in vitro skin sensitisation: in vitro skin sensitisation assays addressing the key event on activation of dendritic cells on the adverse outcome pathway for skin sensitisation. OECD guidelines for the testing of chemicals, section 4: health effects. Paris, France: OECD Publishing.
  • Ogura Y, Mishra V, Hindi SM, et al. (2013). Proinflammatory cytokine tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) suppresses satellite cell self-renewal through inversely modulating Notch and NF-κB signaling pathways. J Biol Chem 288:35159–69.
  • Ryan CA, Gerberick GF, Gildea LA, et al. (2005). Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol Sci 88:4–11.
  • Ryan CA, Kimber I, Basketter DA, et al. (2007). Dendritic cells and skin sensitization: Biological roles and uses in hazard identification. Toxicol Appl Pharmacol 221:384–94.
  • Sakaguchi H, Miyazawa M, Yoshida Y, et al. (2007). Prediction of preservative sensitization potential using surface marker CD86 and/or CD54 expression on human cell line, THP-1. Arch Dermatol Res 298:427–37.
  • Sakaguchi H, Ryan C, Ovigne JM, et al. (2010). Predicting skin sensitization potential and inter-laboratory reproducibility of a human Cell Line Activation Test (h-CLAT) in the European Cosmetics Association (COLIPA) ring trials. Toxicol In Vitro 24:1810–20.
  • Saitoh T, Nakayama M, Nakano H, et al. (2003). TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem 278:36005–12.
  • Schmittgen TD, Livak KJ. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protocol 3:1101–8.
  • Schoeters E, Verheyen GR, Nelissen I, et al. (2007). Microarray analyses in dendritic cells reveal potential biomarkers for chemical-induced skin sensitization. Mol Immunol 44:3222–33.
  • Sutterwala FS, Ogura Y, Szczepanik M, et al. (2006). Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317–27.
  • Tietze C, Blomeke B. (2008). Sensitization assays: monocyte-derived dendritic cells versus a monocytic cell line (THP-1). J Toxicol Environ Health Part A 71:965–8.
  • Watanabe H, Gaide O, Pétrilli V, et al. (2007). Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 127:1956–63.
  • Weltzien HU, Corsini E, Gibbs S, et al. (2009). Safe cosmetics without animal testing? Contributions of the EU Project Sens-it-iv. J Verbrauch Lebensm 4:41–8.
  • Wiley SR, Cassiano L, Lofton T, et al. (2001). A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15:837–46.
  • Wiley SR, Winkles JA. (2003). TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Fact Rev 14:241–9.
  • Yoshida Y, Sakaguchi H, Ito Y, et al. (2003). Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol In Vitro 17:221–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.